The 2016 Bullish and Bearish Case for American Express and Visa
The major credit cards of the Dow had a somewhat mixed year, with Visa the obvious winner as a card processor, while American Express went south as a credit card issuer.
All Work
Chris Lange
Finish Line Earnings Stumble Over Supply Chain Disruption
Finish Line reported disappointing fiscal third-quarter financial results before the markets opened on Thursday.
Macy’s Accommodates for Weak Holiday Sales With Cost-Efficient Initiatives
Macy's had a tough run over the holiday season and the company suffered, but no one thought that it might be this bad.
The 2016 Bullish and Bearish Case for Goldman Sachs and JPMorgan
If analysts end up being correct in 2016, the bank holding company stocks could bring double-digit gains in the year ahead.
What to Expect From Finish Line Earnings
Finish Line Inc. (NASDAQ: FINL) is scheduled to report its fiscal third quarter financial results before the markets open on Thursday. The consensus estimates call for a net loss per share of $0.04 on…
How Does an Argentine Bank IPO Sound?
Before readers think that this may be a hoax, it is not. How would most investors feel about buying into an Argentine financial group that owns a bank? After all, the financial history of…
JPMorgan Settles Misstatement With SEC for $4 Million
The SEC has announced that JPMorgan's brokerage business agreed to pay $4 million to settle charges of making false statements.
The 2016 Bullish and Bearish Case for Apple
24/7 Wall St. is looking forward to see what the strategists and analysts on Wall Street expect for the stock market and the major stocks in 2016, in this case Apple.
Visterra Readies for IPO
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Transfirst Holdings Prepares to Enter the Market in Most Recent IPO Filing
Transfirst Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Tabula Rasa HealthCare Takes First Step Toward IPO
The U.S. Securities and Exchange Commission (SEC) has received a filing from Tabula Rasa HealthCare regarding its initial public offering (IPO).
Exelixis Posts Positive Late Stage Results in METEOR trial
Exelixis Inc. (NASDAQ: EXEL) was up slightly in Tuesday’s trading session following positive results from a late stage trial. The company announced the presentation of positive data from subgroup analyses of METEOR, the Phase…
Janney Weighs in on Acceleron Pharma
Janney Capital has weighed in on biotech company Acceleron Pharma and what its outlook stands to be for the future.
Mannkind Sinks on Afrezza License Termination
MannKind Corp. (NASDAQ: MNKD) is one of the most traded biotech companies on the market, and one of the most shorted as well. In Tuesday’s session the stock took a big downturn after the…
Akebia Plans to Raise Capital in Most Recent Proposed Offering
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
What to Expect From Sonic Earnings
Restaurant operator Sonic is set to report its fiscal first-quarter financial results after the markets close on Tuesday.
Accenture Adds to Cloud Portfolio With Newest Acquisition
Accenture acquired CRMWaypoint, a supplier of cloud advisory and technology services in the Netherlands.
Bavarian Nordic Files for IPO
Bavarian Nordic has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
What to Expect From the Federal Reserve in 2016
The Federal Reserve just raised interest rates, but what does that mean for the everyday consumer?